Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Clin Cancer Res. 2010 Feb 16;16(5):1642–1651. doi: 10.1158/1078-0432.CCR-09-2701

Figure 2.

Figure 2

No correlation between intensity and frequency of T cell response to individual HY peptides in FM patients.

The percentage of FM patients (n=28) with a positive response to each HY peptide (n=13) is shown on the X axis. The Y axis illustrates the magnitude of response to each HY peptide (spots/200,000 cells) in the same individuals. The open square represents the previously reported HY (JARID1D311), which elicited a relatively strong response but this was only detected in 33.3% of FM patients.